Comparison of Somatostatin Analogue (SA) and Chemotherapy (CT) in Neuroendocrine Tumors (NET) Patients with Ki-67 <= 20%

Ozaslan, E.Koca, S.Sevinc, A.Hacioglu, B.Ozcelik, M.Duran, A. O.Yildiz, Y.Tanriverdi, O.Menekse, S.Aksoy, A.Elmaci, S.Uysal, M.Ciltas, A.2019-07-272019-07-282019-07-272019-07-2820160028-38351423-0194https://hdl.handle.net/20.500.12418/753113th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease -- MAR 09-11, 2016 -- Barcelona, SPAIN…eninfo:eu-repo/semantics/closedAccessSomatostatin analogueNETKi-67Comparison of Somatostatin Analogue (SA) and Chemotherapy (CT) in Neuroendocrine Tumors (NET) Patients with Ki-67 <= 20%Conference Object1037474WOS:000386481600195Q2